Your browser doesn't support javascript.
Imatinib is not a potent anti-SARS-CoV-2 drug.
Zhao, Helong; Mendenhall, Michelle; Deininger, Michael W.
  • Zhao H; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Mendenhall M; Institute for Antiviral Research, Utah State University, Logan, UT, USA.
  • Deininger MW; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA. Michael.Deininger@hci.utah.edu.
Leukemia ; 34(11): 3085-3087, 2020 11.
Article in English | MEDLINE | ID: covidwho-1387182

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pyrazoles / Niacinamide / Protein Kinase Inhibitors / Imatinib Mesylate / Betacoronavirus Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2020 Document Type: Article Affiliation country: S41375-020-01045-9

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pyrazoles / Niacinamide / Protein Kinase Inhibitors / Imatinib Mesylate / Betacoronavirus Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2020 Document Type: Article Affiliation country: S41375-020-01045-9